• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素对乳腺癌细胞生长及信号传导的影响。

Effects of adiponectin on breast cancer cell growth and signaling.

作者信息

Grossmann M E, Nkhata K J, Mizuno N K, Ray A, Cleary M P

机构信息

Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.

出版信息

Br J Cancer. 2008 Jan 29;98(2):370-9. doi: 10.1038/sj.bjc.6604166. Epub 2008 Jan 8.

DOI:10.1038/sj.bjc.6604166
PMID:18182989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2361440/
Abstract

Obesity is a risk factor for postmenopausal breast cancer. Adiponectin/Acrp30 is lower in obese individuals and may be negatively regulating breast cancer growth. Here we determined that five breast cancer cell lines, MDA-MB-231, MDA-MB-361, MCF-7, T47D, and SK-BR-3, expressed one or both of the Acrp30 receptors. In addition, we found that the addition of Acrp30 to MCF-7, T47D, and SK-BR-3 cell lines inhibited growth. Oestrogen receptor (ER) positive MCF-7 and T47D cells were inhibited at lower Acrp30 concentrations than ER-negative SK-BR-3 cells. Growth inhibition may be related to apoptosis since PARP cleavage was increased by Acrp30 in the ER-positive cell lines. To investigate the role of ER in the response of breast cancer cells to Acrp30, we established the MDA-ERalpha7 cell line by insertion of ER-alpha into ER-alpha-negative MDA-MB-231 cells. This line readily formed tumours in athymic mice and was responsive to oestradiol in vivo. In vitro, MDA-ERalpha7 cells were growth inhibited by globular Acrp30 while the parental cells were not. This inhibition appeared to be due to blockage of JNK2 signalling. These results provide information on how obesity may influence breast cancer cell proliferation and establish a new model to examine interactions between ER and Acrp30.

摘要

肥胖是绝经后乳腺癌的一个风险因素。脂联素/Acrp30在肥胖个体中水平较低,可能对乳腺癌生长起负调控作用。在此,我们确定了五种乳腺癌细胞系,即MDA-MB-231、MDA-MB-361、MCF-7、T47D和SK-BR-3,表达一种或两种Acrp30受体。此外,我们发现向MCF-7、T47D和SK-BR-3细胞系中添加Acrp30会抑制其生长。雌激素受体(ER)阳性的MCF-7和T47D细胞在较低的Acrp30浓度下就受到抑制,而ER阴性的SK-BR-3细胞则不然。生长抑制可能与细胞凋亡有关,因为在ER阳性细胞系中,Acrp30会增加PARP的裂解。为了研究ER在乳腺癌细胞对Acrp30反应中的作用,我们通过将ER-α插入ER-α阴性的MDA-MB-231细胞中,建立了MDA-ERalpha7细胞系。该细胞系在无胸腺小鼠中易于形成肿瘤,且在体内对雌二醇有反应。在体外,球状Acrp30可抑制MDA-ERalpha7细胞的生长,而亲本细胞则不受影响。这种抑制作用似乎是由于JNK2信号通路受阻所致。这些结果提供了关于肥胖如何影响乳腺癌细胞增殖的信息,并建立了一个新模型来研究ER与Acrp30之间的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/4709a9fc77d5/6604166f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/1be76b22bda9/6604166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/f1bafcf9bfd1/6604166f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/3c9b11fa10c2/6604166f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/ff2a6f93f102/6604166f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/4709a9fc77d5/6604166f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/1be76b22bda9/6604166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/f1bafcf9bfd1/6604166f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/3c9b11fa10c2/6604166f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/ff2a6f93f102/6604166f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7c/2361440/4709a9fc77d5/6604166f5.jpg

相似文献

1
Effects of adiponectin on breast cancer cell growth and signaling.脂联素对乳腺癌细胞生长及信号传导的影响。
Br J Cancer. 2008 Jan 29;98(2):370-9. doi: 10.1038/sj.bjc.6604166. Epub 2008 Jan 8.
2
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.人乳腺癌细胞系中基底膜侵袭性增加与雌激素受体缺失及波形蛋白表达的关联。
J Cell Physiol. 1992 Mar;150(3):534-44. doi: 10.1002/jcp.1041500314.
3
[Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].白细胞介素-8在乳腺癌中的血管生成作用及其与雌激素受体的关系
Zhonghua Yi Xue Za Zhi. 2005 Jun 1;85(20):1419-23.
4
P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.P2Y2 受体介导的雌激素诱导的乳腺癌细胞增殖的调节作用。
Mol Cell Endocrinol. 2011 May 16;338(1-2):28-37. doi: 10.1016/j.mce.2011.02.014. Epub 2011 Feb 26.
5
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.雌激素受体(ER)阳性的MCF-7和ER阴性的MDA-MB-231乳腺癌细胞中胰岛素样生长因子I受体信号传导及功能的差异
Cancer Res. 2001 Sep 15;61(18):6747-54.
6
Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.辣椒素通过调节 EGFR/HER-2 通路,导致 ER 阳性和阴性乳腺癌细胞的细胞周期停滞和细胞凋亡。
Oncogene. 2010 Jan 14;29(2):285-96. doi: 10.1038/onc.2009.335. Epub 2009 Oct 26.
7
Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.核酶介导的雌激素受体阳性乳腺癌细胞中ErbB-4的下调抑制体外和体内增殖。
Cancer Res. 1999 Oct 15;59(20):5315-22.
8
Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol.脂联素对人乳腺癌细胞的作用依赖于17-β雌二醇。
Oncol Rep. 2008 Mar;19(3):787-93.
9
Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.灵芝通过下调雌激素受体和核因子κB信号通路抑制人乳腺癌细胞的增殖。
Int J Oncol. 2006 Sep;29(3):695-703.
10
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.1,1-双(3'-吲哚基)-1-(对-取代苯基)甲烷通过激活多种途径抑制雌激素受体阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2008 May;109(2):273-83. doi: 10.1007/s10549-007-9648-y. Epub 2007 Jul 12.

引用本文的文献

1
The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis.乳腺癌生物标志物在诊断、预后及治疗监测中的评估:综合分析
J Cancer Res Clin Oncol. 2025 Aug 22;151(8):233. doi: 10.1007/s00432-025-06271-1.
2
Association of adiponectin gene polymorphism with adipokine and lipid profile in breast cancer patients from Kano, Nigeria.尼日利亚卡诺乳腺癌患者脂联素基因多态性与脂肪因子及血脂谱的关联
Breast Cancer. 2025 Aug 13. doi: 10.1007/s12282-025-01758-8.
3
Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae.

本文引用的文献

1
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.脂肪因子作为乳腺癌风险和进展中的内分泌、旁分泌和自分泌因子。
Endocr Relat Cancer. 2007 Jun;14(2):189-206. doi: 10.1677/ERC-06-0068.
2
Adiponectin as a negative regulator in obesity-related mammary carcinogenesis.脂联素作为肥胖相关乳腺癌发生发展中的负调控因子。
Cell Res. 2007 Apr;17(4):280-2. doi: 10.1038/cr.2007.14.
3
Diet-induced obesity and mammary tumor development in relation to estrogen receptor status.饮食诱导的肥胖与乳腺肿瘤发生发展与雌激素受体状态的关系。
2 型糖尿病和脂肪组织功能障碍对乳腺癌的影响,以及微藻中诱导的营养保健品的潜在益处。
Nutrients. 2024 Sep 25;16(19):3243. doi: 10.3390/nu16193243.
4
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer.肥胖和胰岛素抵抗对雌激素受体阳性乳腺癌治疗的影响。
Br J Cancer. 2024 Dec;131(11):1724-1736. doi: 10.1038/s41416-024-02833-1. Epub 2024 Sep 9.
5
Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.非酒精性脂肪性肝病通过上调肝成纤维细胞生长因子 21 促进乳腺癌进展。
Cell Death Dis. 2024 Jan 18;15(1):67. doi: 10.1038/s41419-023-06386-8.
6
Reversion of breast epithelial polarity alterations caused by obesity.肥胖引起的乳腺上皮极性改变的逆转。
NPJ Breast Cancer. 2023 May 9;9(1):35. doi: 10.1038/s41523-023-00539-w.
7
Targeting Adiponectin in Breast Cancer.靶向乳腺癌中的脂联素
Biomedicines. 2022 Nov 17;10(11):2958. doi: 10.3390/biomedicines10112958.
8
The EASO New Investigator Award in Clinical Research 2021: Role of Chronotype in Obesity.2021 年欧洲庇护所管理局临床研究新研究员奖:时型在肥胖中的作用。
Obes Facts. 2023;16(2):131-140. doi: 10.1159/000527691. Epub 2022 Nov 8.
9
The pleiotropic roles of adipocyte secretome in remodeling breast cancer.脂肪细胞分泌组在重塑乳腺癌中的多效作用。
J Exp Clin Cancer Res. 2022 Jun 14;41(1):203. doi: 10.1186/s13046-022-02408-z.
10
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.合成脂联素受体激动剂 AdipoRon 诱导胰腺癌细胞的糖酵解依赖性。
Cell Death Dis. 2022 Feb 4;13(2):114. doi: 10.1038/s41419-022-04572-8.
Cancer Lett. 2007 Aug 18;253(2):291-300. doi: 10.1016/j.canlet.2007.02.005. Epub 2007 Mar 30.
4
Adiponectin in health and disease.健康与疾病中的脂联素。
Diabetes Obes Metab. 2007 May;9(3):282-9. doi: 10.1111/j.1463-1326.2006.00610.x.
5
Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.在雌激素受体α(ERα)阴性的人乳腺癌细胞系中通过异位表达ERα抑制骨转移
Neoplasia. 2007 Feb;9(2):113-8. doi: 10.1593/neo.06784.
6
Adiponectin as an anti-inflammatory factor.脂联素作为一种抗炎因子。
Clin Chim Acta. 2007 May 1;380(1-2):24-30. doi: 10.1016/j.cca.2007.01.026. Epub 2007 Feb 2.
7
New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast.雌激素受体在人类乳腺中的生物学及临床相关性的新视角
J Pathol. 2007 Apr;211(5):499-506. doi: 10.1002/path.2130.
8
Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer.脂联素对MCF7乳腺癌细胞的抗增殖作用:肥胖与癌症之间潜在的激素联系。
Horm Metab Res. 2007 Jan;39(1):9-13. doi: 10.1055/s-2007-956518.
9
Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response?间歇性热量限制对乳腺肿瘤发生的预防作用:再喂养期间的热量摄入是否会调节反应?
Exp Biol Med (Maywood). 2007 Jan;232(1):70-80.
10
Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.乳腺癌中的总脂联素和高分子量脂联素:体外和体内研究
J Clin Endocrinol Metab. 2007 Mar;92(3):1041-8. doi: 10.1210/jc.2006-1858. Epub 2006 Dec 27.